Skip to content

Proglycan CCD-Blocker

by Proglycan GmbH 3 variants

Ref PGB-200

Active European Union

CE IVDR

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number912012638MUXF_HSA01HX Basic UDI-DI 09120126380020UDI-DIDate1 Mar 2023RegisteredStatusActive

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDR Active

Specification

EUDAMED

Device Name
Proglycan CCD-Blocker
Model / Reference
PGB-200
Primary DI / UDI-DI
09120126380020
Basic UDI-DI
912012638MUXF_HSA01HX
Direct Marketing DI
09120126380020
EMDN Code
W01010299 Substrates - other
Device Class
Class A
EU market of registration
Austria

Manufacturer details

EUDAMED SRN
AT-MF-000029847

Other devices from Proglycan GmbH

Properties

  • Human Tissues
  • Professional Testing

Other properties (9)

  • Sterile: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No